K
4.63
-0.15 (-3.04%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | KALA BIO, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.13 |
|
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA’smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 1.91% |
| 机构持股比例 | 64.18% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 33.00 (Oppenheimer, 613.51%) | 购买 |
| 中 | 31.50 (581.08%) | |
| 低 | 30.00 (Mizuho, 548.65%) | 购买 |
| 平均值 | 31.50 (581.08%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 15.74 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Oppenheimer | 11 Sep 2025 | 33.00 (613.51%) | 购买 | 17.00 |
| Mizuho | 08 Sep 2025 | 30.00 (548.65%) | 购买 | 14.48 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合